Vice President, Biotech Private Equity
CurrentAlly Bridge Group is a global healthcare investment firm focused on high-impact life science innovation. Since our founding in 2013, the firm has been the lead or co-lead investor on over $6 billion of transactions across healthcare subsectors. Our mission is to generate superior risk-adjusted returns for investors while seeking to address unmet medical needs. We aim to achieve this by blending deep scientific domain knowledge with proven M&A and capital markets expertise.